PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pneumococcal Disease

Merck Reports Results of Vaxneuvance (pneumococcal 15-valent conjugate vaccine) in P-III PNEU-PED Study for the Prevention of Invasive Pneumococcal Disease

Merck Reports Results of Vaxneuvance (pneumococcal 15-valent conjugate vaccine) in P-III PNEU-PED Study for the Prevention of Inva...

August 26, 2021

Merck's Vaxneuvance (pneumococcal 15-valent conjugate vaccine) Receives the US FDA's Approval for the Prevention of Invasive Pneumococcal Disease Caused by 15 Serotypes

Merck's Vaxneuvance (pneumococcal 15-valent conjugate vaccine) Receives the US FDA's Approval for the Prevention of Invasive Pneum...

July 19, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us